Cargando…
NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer
BACKGROUND: Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear. METHODS: A total of 52 T1-2N0 laryngeal cancer patients were enrolled. Of these, 42 t...
Autores principales: | Gong, Xiao-yang, Chen, Hai-bin, Zhang, Li-qing, Chen, Dong-sheng, Li, Wang, Chen, Dong-hui, Xu, Jin, Zhou, Han, Zhao, Le-le, Song, Yun-jie, Xiao, Ming-zhe, Deng, Wang-long, Qi, Chuang, Wang, Xue-rong, Chen, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336464/ https://www.ncbi.nlm.nih.gov/pubmed/35911687 http://dx.doi.org/10.3389/fimmu.2022.920253 |
Ejemplares similares
-
Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis
por: He, Sha-sha, et al.
Publicado: (2017) -
Effect of Notch1 signaling on cellular proliferation and apoptosis in human laryngeal carcinoma
por: Li, Dawei, et al.
Publicado: (2022) -
Case Report: Adjuvant Crizotinib Therapy Exerted Favorable Survival Benefit in a Resectable Stage IIIA NSCLC Patient With Novel LDLR–ROS1 Fusion
por: Chen, An-guo, et al.
Publicado: (2022) -
[Corrigendum] Downregulation of Notch1 induces apoptosis and inhibits cell proliferation and metastasis in laryngeal squamous cell carcinoma
por: Dai, Meng-Yuan, et al.
Publicado: (2023) -
Notch signaling in lung diseases: focus on Notch1 and
Notch3
por: Zong, Dandan, et al.
Publicado: (2016)